A potential risk factor for paraoxonase 1: in silico and in‐vitro analysis of the biological activity of proton‐pump inhibitors

Investigation of Potential Paraoxonase-I Inhibitors by Kinetic and Molecular Docking Studies: Chemotherapeutic Drugs

(2019) Cüneyt Türkeş   PROTEIN AND PEPTIDE LETTERS

The inhibition Effects of Some Sulfonamides on Human Serum Paraoxonase-1 (hPON1)

(2019) Yeliz Demir et al.   Pharmacological Reports

Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies

(2019) Şükrü Beydemir et al.   DRUG AND CHEMICAL TOXICOLOGY

Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors

(2019) Cüneyt Türkeş et al.   BIOORGANIC CHEMISTRY

Substrates for Paraoxonase

(2018) Xiaojing Mu et al.   CURRENT PHARMACEUTICAL DESIGN

The effect of divalent metal chelators and cadmium on serum phosphotriesterase, lactonase and arylesterase activities of paraoxonase 1

(2018) Anna Bizoń et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Synthesis and drug efficacy validations of racemic-substituted benzimidazoles as antiulcer/antigastric secretion agents

(2018) Rajesh Radhamanalan et al.   Future Medicinal Chemistry

Evaluation of chalcones as inhibitors of glutathione S-transferase

(2018) Muhammet Serhat Özaslan et al.   JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease

(2018) Guisong Wang et al.   PLoS One

Proton pump inhibitors (PPIs) may cause gastric cancer – clinical consequences

(2018) Helge L. Waldum et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?

(2018) Atena Variji et al.   ATHEROSCLEROSIS

Interaction between MTHFR 677C>T, PON1 192Q>R and PON1 55L>M polymorphisms and its effect on non-recurrent spontaneous abortion in Mexican women

(2018) Julia Blanco-Muñoz et al.   GENE

Effects of Paraoxonase-1 variants on course of severity and mortality of Crimean-Congo hemorrhagic fever

(2018) Nevin Karakus et al.   GENE

Nannochloropsis sp. ethanol extract prevents macrophage and LDL oxidation and enhances PON1 activity through the principal active compound lyso-diacylglyceryltrimethylhomoserine (lyso-DGTS)

(2017) Soliman Khatib et al.   JOURNAL OF APPLIED PHYCOLOGY

Assessment of the inhibitory effects and molecular docking of some sulfonamides on human serum paraoxonase 1

(2017) Zuhal Alim et al.   JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis

(2017) Surapon Nochaiwong et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Association Between Proton Pump Inhibitors and Microscopic Colitis

(2016) Ernest H. Law et al.   ANNALS OF PHARMACOTHERAPY

Some Anticancer Agents Act on Human Serum Paraoxonase-1 to Reduce Its Activity

(2016) Zuhal Alim et al.   Chemical Biology & Drug Design

Effects of antiretroviral treatment on paraoxonase 1 (PON1) activity in rats

(2016) Jolanta Elżbieta Pastryk et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Proton pump inhibitors and osteoporosis

(2016) Bjarne Nesgaard Andersen et al.   CURRENT OPINION IN RHEUMATOLOGY

In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum

(2016) Cüneyt Türkeş et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Potent Inhibitory Effects of Some Phenolic Acids on Lactoperoxidase

(2016) Zeynep Koksal et al.   JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

Antiepileptic drugs: Impacts on human serum paraoxonase-1

(2016) Şükrü Beydemir et al.   JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

Purification, refolding, and characterization of recombinant human paraoxonase-1

(2015) Yeliz DEMİR et al.   TURKISH JOURNAL OF CHEMISTRY

Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis

(2015) Allison A. Lambert et al.   PLoS One

Human serum paraoxonase-1 (hPON1):in vitroinhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium

(2014) Cüneyt Türkeş et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress

(2014) Cüneyt Türkeş et al.   Pharmacological Reports

Unexpected Effect of Proton Pump Inhibitors

(2013) Yohannes T. Ghebremariam et al.   CIRCULATION

Use of proton pump inhibitors and subsequent risk of celiac disease

(2013) Benjamin Lebwohl et al.   DIGESTIVE AND LIVER DISEASE

Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B12Deficiency

(2013) Jameson R. Lam et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

(2013) G. Madhavi Sastry et al.   JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis

(2012) Chun Shing Kwok et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor

(2012) Shaun G. Goodman et al.   CIRCULATION

Synthesis and paroxonase activities of novel bromophenols

(2012) Yusuf Akbaba et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Accumulating Evidence for a Drug-Drug Interaction Between Methotrexate and Proton Pump Inhibitors

(2012) S. Bezabeh et al.   ONCOLOGIST

Effects of some anti-neoplastic drugs on sheep liver sorbitol dehydrogenase

(2012) Zuhal Alım et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

(2011) C. Bavishi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Association Between Proton Pump Inhibitor Use and Anemia: A Retrospective Cohort Study

(2011) Erin Sarzynski et al.   DIGESTIVE DISEASES AND SCIENCES

An Alternative Purification Method for Human Serum Paraoxonase 1 and its Interactions with Sulfonamides

(2010) Deniz Ekinci et al.   Chemical Biology & Drug Design

Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum

(2010) Mehmet Mustafa İşgör et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases

(2009) Deniz Ekinci et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Identifying and Characterizing Binding Sites and Assessing Druggability

(2009) Thomas A. Halgren   Journal of Chemical Information and Modeling

Proton pump inhibitors: predisposers to Alzheimer disease?

(2009) M. K. Fallahzadeh et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Effect of some analgesics on Paraoxonase-1 purified from human serum

(2009) Deniz EKİNCİ et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY